Eriksson JE - Search Results

1

The antitumor lignan Nortrachelogenin sensitizes prostate cancer cells to TRAIL-induced cell death by inhibition of the Akt pathway and growth factor signaling.

Peuhu E, Paul P, Remes M, Holmbom T, Eklund P, Sjöholm R, Eriksson JE. Peuhu E, et al. Among authors: eriksson je. Biochem Pharmacol. 2013 Sep 1;86(5):571-83. doi: 10.1016/j.bcp.2013.05.026. Epub 2013 Jun 6. Biochem Pharmacol. 2013. PMID: 23747345

2

Inhibition of mitogen-activated kinase signaling sensitizes HeLa cells to Fas receptor-mediated apoptosis.

Holmström TH, Tran SE, Johnson VL, Ahn NG, Chow SC, Eriksson JE. Holmström TH, et al. Among authors: eriksson je. Mol Cell Biol. 1999 Sep;19(9):5991-6002. doi: 10.1128/MCB.19.9.5991. Mol Cell Biol. 1999. PMID: 10454546 Free PMC article.

3

Mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in activated T cells abrogates TRAIL-induced apoptosis upstream of the mitochondrial amplification loop and caspase-8.

Söderström TS, Poukkula M, Holmström TH, Heiskanen KM, Eriksson JE. Söderström TS, et al. Among authors: eriksson je. J Immunol. 2002 Sep 15;169(6):2851-60. doi: 10.4049/jimmunol.169.6.2851. J Immunol. 2002. PMID: 12218097

4

Erythroid differentiation sensitizes K562 leukemia cells to TRAIL-induced apoptosis by downregulation of c-FLIP.

Hietakangas V, Poukkula M, Heiskanen KM, Karvinen JT, Sistonen L, Eriksson JE. Hietakangas V, et al. Among authors: eriksson je. Mol Cell Biol. 2003 Feb;23(4):1278-91. doi: 10.1128/MCB.23.4.1278-1291.2003. Mol Cell Biol. 2003. PMID: 12556488 Free PMC article.

5

Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors.

Ahonen M, Poukkula M, Baker AH, Kashiwagi M, Nagase H, Eriksson JE, Kähäri VM. Ahonen M, et al. Among authors: eriksson je. Oncogene. 2003 Apr 10;22(14):2121-34. doi: 10.1038/sj.onc.1206292. Oncogene. 2003. PMID: 12687014

6

Type-2A protein phosphatase activity is required to maintain death receptor responsiveness.

Härmälä-Braskén AS, Mikhailov A, Söderström TS, Meinander A, Holmström TH, Damuni Z, Eriksson JE. Härmälä-Braskén AS, et al. Among authors: eriksson je. Oncogene. 2003 Oct 23;22(48):7677-86. doi: 10.1038/sj.onc.1207077. Oncogene. 2003. PMID: 14576831

7

Regulation of death receptors--relevance in cancer therapies.

de Thonel A, Eriksson JE. de Thonel A, et al. Among authors: eriksson je. Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):123-32. doi: 10.1016/j.taap.2005.03.032. Toxicol Appl Pharmacol. 2005. PMID: 16126242 Review.

8

CD73 participates in cellular multiresistance program and protects against TRAIL-induced apoptosis.

Mikhailov A, Sokolovskaya A, Yegutkin GG, Amdahl H, West A, Yagita H, Lahesmaa R, Thompson LF, Jalkanen S, Blokhin D, Eriksson JE. Mikhailov A, et al. Among authors: eriksson je. J Immunol. 2008 Jul 1;181(1):464-75. doi: 10.4049/jimmunol.181.1.464. J Immunol. 2008. PMID: 18566412 Free PMC article.

9

Targeting of porous hybrid silica nanoparticles to cancer cells.

Rosenholm JM, Meinander A, Peuhu E, Niemi R, Eriksson JE, Sahlgren C, Lindén M. Rosenholm JM, et al. Among authors: eriksson je. ACS Nano. 2009 Jan 27;3(1):197-206. doi: 10.1021/nn800781r. ACS Nano. 2009. PMID: 19206267

10

Targeted intracellular delivery of hydrophobic agents using mesoporous hybrid silica nanoparticles as carrier systems.

Rosenholm JM, Peuhu E, Eriksson JE, Sahlgren C, Lindén M. Rosenholm JM, et al. Among authors: eriksson je. Nano Lett. 2009 Sep;9(9):3308-11. doi: 10.1021/nl901589y. Nano Lett. 2009. PMID: 19736973

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

185 results

Search Page

Filters